Knee Replacement News and Research RSS Feed - Knee Replacement News and Research

ProfNet network experts available to discuss timely issues in your coverage area

ProfNet network experts available to discuss timely issues in your coverage area

Below are experts from the ProfNet network that are available to discuss timely issues in your coverage area. You can also submit a query to the hundreds of thousands of experts in our network – it's easy and free! [More]
Readmission to same hospital for post-surgical complications improves survival

Readmission to same hospital for post-surgical complications improves survival

Patients rehospitalized with complications after major surgery are 26% more likely to survive if they return to the hospital where they had their operation compared to those readmitted to a different hospital, according to a national study involving over 9 million Medicare patients in the USA, published in The Lancet. [More]
Heparin market in Europe estimated to reach USD 3,148.0 million by 2022

Heparin market in Europe estimated to reach USD 3,148.0 million by 2022

According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the Heparin Market Europe was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022. [More]
Simple pre-surgical intervention can reduce S aureus surgical site infections

Simple pre-surgical intervention can reduce S aureus surgical site infections

Implementation of a pre-surgical intervention that included screening for the bacteria Staphylococcus aureus, treating patients who were positive for this bacteria, and the administration of antibiotics based on these culture results was associated with a modest reduction in S aureus surgical site infections, according to a study in the June 2 issue of JAMA. [More]
Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types. [More]
Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic Hospitals in Rochester, Minn, and Phoenix earned the top-tier High Performing distinction in all five common care categories in the latest ratings by U.S. News & World Report. [More]

Touch surgery awarded Rising Star award at Founders Forum

The accolade of Smart Nation Rising Star comes on the heels a public announcement that the Touch Surgery app is now used by over 200,000 surgeons in every country on earth... [More]
Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

U.S. News & World Report, publisher of Best Hospitals and Best Children's Hospitals, today announced that Kaiser Permanente and Intermountain Healthcare will participate in the U.S. News Hospital Outcome Data Disclosure Program, a new data-collection initiative designed to evaluate hospitals more completely and give patients better information about the hospitals in their communities. [More]
UI orthopedics researchers working on injectable, bioactive gel that can repair cartilage damage

UI orthopedics researchers working on injectable, bioactive gel that can repair cartilage damage

Knee injuries are the bane of athletes everywhere, from professionals and college stars to weekend warriors. Current surgical options for repairing damaged cartilage caused by knee injuries are costly, can have complications, and often are not very effective in the long run. Even after surgery, cartilage degeneration can progress leading to painful arthritis. [More]

FDA announces voluntary recall of Zimmer knee product

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that the FDA announced a Class II recall for Zimmer's Persona Trabecular Metal Tibial Plate knee implant. The recall affects all lots and sizes of the knee implant, affecting all 11,658 devices that were recalled, according to the FDA's website. [More]
Blue Cross Blue Shield of Michigan, UMHS collaborate to improve quality of care for Michiganians

Blue Cross Blue Shield of Michigan, UMHS collaborate to improve quality of care for Michiganians

Blue Cross Blue Shield of Michigan and the University of Michigan Health System will collaborate with emergency physicians at participating hospitals across the state to develop best practices to improve the experience and outcomes of patients receiving care in emergency departments. [More]
Moirai Orthopaedics receives FDA approval for IDE application to initiate clinical study of PIR System

Moirai Orthopaedics receives FDA approval for IDE application to initiate clinical study of PIR System

Moirai Orthopaedics, L.L.C., an orthopaedic implant development company based in Metairie, Louisiana, is pleased to announce it has received approval from the US Food and Drug Administration for its Investigational Device Exemption (IDE) application to initiate clinical study of the company's Pyrocarbon Implant Replacement (PIR) System. [More]
Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Jersey Shore has earned The Joint Commission's Gold Seal of Approval for its Hip and Knee Joint Replacement Program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care. The certification award recognizes the hospital's dedication to continuous compliance with The Joint Commission's rigorous standards. [More]
Penn surgeons develop new tools to identify joint replacement patients at risk for serious complications

Penn surgeons develop new tools to identify joint replacement patients at risk for serious complications

Orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania have developed two new prediction tools aimed at identifying total hip and knee replacement patients who are at-risk of developing serious complications after surgery. [More]
Bariatric surgery prior to joint replacement improves outcomes in obese patients

Bariatric surgery prior to joint replacement improves outcomes in obese patients

Obesity is not only a risk factor for developing knee and hip arthritis. It is also linked to less favorable outcomes after joint replacement surgery. [More]
Data demonstrates benefits associated with use of EXPAREL in hip, knee replacement patients

Data demonstrates benefits associated with use of EXPAREL in hip, knee replacement patients

Pacira Pharmaceuticals, Inc. today announced data demonstrating the benefits associated with the use of EXPAREL (bupivacaine liposome injectable suspension) in a study of over 2,200 hip and knee replacement patients. [More]
Women who undergo total joint replacement surgery less likely to have complications compared to men

Women who undergo total joint replacement surgery less likely to have complications compared to men

While women may have their first total joint replacement (TJR) at an older age, they are less likely to have complications related to their surgery or require revision surgery, according to a new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons. [More]
Functional scores are higher in men before and after TKR surgery, shows study

Functional scores are higher in men before and after TKR surgery, shows study

While men and women have similar levels of improvement following total knee replacement (TKR) surgery, men have higher levels of function before and after TKR, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). [More]
Stem cell treatment for osteoarthritis of the knee may help rebuild lost cartilage

Stem cell treatment for osteoarthritis of the knee may help rebuild lost cartilage

Recent studies employing adult stem cells obtained from bone marrow and fat have been used in patients suffering from osteoarthritis of the knee. Results have indicated not only symptomatic improvement but also suggest that cartilage healing and regeneration may be taking place. [More]

OrthoSensor raises $19 million in Series C Preferred Stock financing

OrthoSensor, Inc., the leader in Sensor-Assisted Surgery, announced today that it has raised $19 million in a private placement of Series C Preferred Stock. Bridger Healthcare, Ltd. and The Tullis Growth Fund, L.P. participated in the round. The proceeds will be used to drive the commercialization of VERASENSE, OrthoSensor's leading product, and expand product development activities. [More]
Advertisement
Advertisement